Brief: Ligand Pharmaceuticals Inc Says Entered Amendment To Credit Agreement Dated Oct 12, 2023
10/07/2024 21:09
July 10 (Reuters) - Ligand Pharmaceuticals Inc LGND.O :
* LIGAND PHARMACEUTICALS INC: ENTERED AMENDMENT TO CREDIT
AGREEMENT DATED OCT 12, 2023
* LIGAND PHARMACEUTICALS INC: AMENDMENT AMENDS CREDIT
AGREEMENT TO
INCREASE REVOLVING CREDIT FACILITY FROM $75 MILLION TO $125
MILLION
Source text for Eikon: ID:n0000886163-24-000059
Further company coverage: LGND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan